dalteparin has been researched along with Injury, Ischemia-Reperfusion in 14 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Since low molecular weight heparin has greater bioavailability and sustained serum levels in vivo than unfractionated heparin, it has been used to supplant unfractionated heparin to achieve therapeutic anticoagulation in humans." | 1.35 | Enoxaparin does not ameliorate limb ischemia-reperfusion injury. ( Abbruzzese, TA; Albadawi, H; Kang, J; Lamuraglia, GM; Patel, VI; Watkins, MT; Yoo, JH, 2008) |
| "Pretreatment with indomethacin completely reversed both of the therapeutic effects of dalteparin, whereas pretreatment with NS-398, a selective inhibitor of cyclooxygenase-2, did not." | 1.33 | Dalteparin, a low molecular weight heparin, attenuates inflammatory responses and reduces ischemia-reperfusion-induced liver injury in rats. ( Harada, N; Okajima, K; Uchiba, M, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 3 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Yan, X | 1 |
| Liang, J | 1 |
| Li, X | 1 |
| Hu, Z | 1 |
| Chen, J | 1 |
| Zheng, J | 1 |
| Li, R | 1 |
| Demirtas, S | 1 |
| Karahan, O | 1 |
| Yazıcı, S | 1 |
| Guclu, O | 1 |
| Calıskan, A | 1 |
| Tezcan, O | 1 |
| Kaplan, I | 1 |
| Yavuz, C | 1 |
| Dogan Ozcil, M | 1 |
| Ozcan, O | 1 |
| Hakverdi, S | 1 |
| Bayraktar, HS | 1 |
| Dirican, E | 1 |
| Kacmaz, F | 1 |
| Bostancı, MS | 1 |
| Budak, O | 1 |
| Çakiroğlu, H | 1 |
| Köse, O | 1 |
| Durmaz, Ö | 1 |
| Cokluk, E | 1 |
| Fındık, O | 1 |
| Yılmaz, MY | 1 |
| Yazır, Y | 1 |
| Rençber, SF | 1 |
| Sarıhan, KK | 1 |
| Kunt, AT | 1 |
| Kaya, C | 1 |
| Turgut, H | 1 |
| Cengiz, H | 1 |
| Turan, A | 1 |
| Ekin, M | 1 |
| Yaşar, L | 1 |
| Cavusoglu, T | 1 |
| Ozcan, N | 1 |
| Ogus, E | 1 |
| Ozcan, A | 1 |
| Kaymak, C | 1 |
| Sahin, S | 1 |
| Yilmaz, FM | 1 |
| Tezel, S | 1 |
| Walensi, M | 1 |
| de Groot, H | 1 |
| Schulz, R | 1 |
| Hartmann, M | 1 |
| Petrat, F | 1 |
| Uzan, A | 1 |
| Welsh, RC | 1 |
| Armstrong, PW | 1 |
| Abbruzzese, TA | 1 |
| Albadawi, H | 1 |
| Kang, J | 1 |
| Patel, VI | 1 |
| Yoo, JH | 1 |
| Lamuraglia, GM | 1 |
| Watkins, MT | 1 |
| Gottmann, U | 1 |
| Mueller-Falcke, A | 1 |
| Schnuelle, P | 1 |
| Birck, R | 1 |
| Nickeleit, V | 1 |
| van der Woude, FJ | 1 |
| Yard, BA | 1 |
| Braun, C | 1 |
| Harada, N | 1 |
| Okajima, K | 1 |
| Uchiba, M | 1 |
| Menger, MD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Influence of Ovarian Torsion and Surgical De-torsion on Ovarian Reserve[NCT03852615] | 100 participants (Anticipated) | Interventional | 2019-03-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for dalteparin and Injury, Ischemia-Reperfusion
| Article | Year |
|---|---|
[Thrombosis and ischemia: experimental data].
Topics: Animals; Apoptosis; Coronary Thrombosis; Disease Models, Animal; Dogs; Enoxaparin; Fibrinolytic Agen | 2002 |
A marriage of enhancement: fibrinolysis and conjunctive therapy.
Topics: Animals; Antithrombins; Aspirin; Blood Platelets; Cell Adhesion; Clinical Trials as Topic; Dose-Resp | 2004 |
2 trials available for dalteparin and Injury, Ischemia-Reperfusion
| Article | Year |
|---|---|
Enoxaparin effect on malondialdehyde levels in laparoscopic cholecystectomy.
Topics: Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; Cholecystectomy, Laparoscopic; Enoxa | 2011 |
Influence of hypersulfated and low molecular weight heparins on ischemia/reperfusion: injury and allograft rejection in rat kidneys.
Topics: Albuminuria; Animals; Anticoagulants; Graft Rejection; Heparin; Heparin, Low-Molecular-Weight; Human | 2007 |
10 other studies available for dalteparin and Injury, Ischemia-Reperfusion
| Article | Year |
|---|---|
Identify Key Genes Correlated to Ischemia-Reperfusion Injury in Aging Livers.
Topics: Aging; Animals; ARNTL Transcription Factors; Humans; Immediate-Early Proteins; Liver; Mice; Nadropar | 2023 |
Investigation of possible prophylactic, renoprotective, and cardioprotective effects of thromboprophylactic drugs against ischemia-reperfusion injury.
Topics: Animals; Anticoagulants; Aryldialkylphosphatase; Aspirin; Cardiotonic Agents; Clopidogrel; Dipeptida | 2015 |
Impact of Enoxaparin +α Lipoic acid combination on oxidative stress, follicle development and apoptotic damage in ovarian ischemia reperfusion model.
Topics: Animals; Antioxidants; Biomarkers; Catalase; Enoxaparin; Female; Follicle Stimulating Hormone; Gluta | 2022 |
Effect of protection of enoxaparin against experimental ischemia/reperfusion injury in the rat ovary on in vitro fertilization outcomes.
Topics: Animals; Anti-Mullerian Hormone; Antioxidants; Enoxaparin; Female; Fertilization in Vitro; Humans; I | 2023 |
Investigation of the protective effect of enoxaparin and ticagrelor pretreatment against ischemia-reperfusion injury in rat lung tissue.
Topics: Animals; Aorta, Abdominal; Apoptosis; Caspase 3; Disease Models, Animal; Enoxaparin; Lung; Lung Inju | 2019 |
Effect of detorsion alone and in combination with enoxaparin therapy on ovarian reserve and serum antimüllerian hormone levels in a rat ovarian torsion model.
Topics: Animals; Anti-Mullerian Hormone; Cell Count; Combined Modality Therapy; Disease Models, Animal; Enox | 2014 |
Mesenteric ischemia-reperfusion injury: clearly improved hemodynamics but only minor protection of the rat small intestine by (sub)therapeutic heparin sodium and enoxaparin doses.
Topics: Animals; Anticoagulants; Blood Pressure; Dose-Response Relationship, Drug; Enoxaparin; Heart Rate; H | 2013 |
Enoxaparin does not ameliorate limb ischemia-reperfusion injury.
Topics: Animals; Anticoagulants; Biomarkers; Enoxaparin; Hindlimb; Inflammation; Male; Mice; Mice, Inbred C5 | 2008 |
Dalteparin, a low molecular weight heparin, attenuates inflammatory responses and reduces ischemia-reperfusion-induced liver injury in rats.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Anticoagulants; Calcium; Cyclooxygenase 2 Inhibitors; Daltepa | 2006 |
Dalteparin: only protective in hepatic ischemia-reperfusion or also capable of preventing injury in liver hyperperfusion syndrome?
Topics: Animals; Anticoagulants; Dalteparin; Fibrinolytic Agents; Liver; Liver Diseases; Rats; Reperfusion I | 2006 |